Literature DB >> 8605013

Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity.

Z Zong1, K Fujikawa-Yamamoto, M Tanino, K Teraoka, H Yamagishi, S Odashima.   

Abstract

Saikosaponin (SS) b2 was found to inhibit the proliferation of B16 melanoma cells. To explore this mechanism, we employed flow cytometry to determine the distribution of DNA content. The cell cycle of B16 melanoma cells was accumulated in the G1 phase followed by induction of apoptosis. This suggests that SSb2-induced proliferation inhibition is caused by G1 phase accumulation and that apoptosis induction is G1-phase-accumulation dependent. Phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, did not interfere with the proliferation and did not induce apoptosis of B16 melanoma cells by itself. However, PMA significantly abolished these effects of SSb2 in including proliferation inhibition and apoptosis induction. Down-regulation of the PKC activity may be involved in the effect of SSb2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605013     DOI: 10.1006/bbrc.1996.0259

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.

Authors:  M Bredel; I F Pollack; J M Freund; J Rusnak; J S Lazo
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Effect of saikosaponin, a triterpene saponin, on apoptosis in lymphocytes: association with c-myc, p53, and bcl-2 mRNA.

Authors:  M J Hsu; J S Cheng; H C Huang
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Saikosaponins: a potential treatment option for systemic lupus erythematosus.

Authors:  G-C Wu; H Wu; L-Y Fan; H-F Pan
Journal:  Ir J Med Sci       Date:  2010-11-26       Impact factor: 1.568

Review 4.  Biochemical and molecular mechanisms regulating apoptosis.

Authors:  K S Saini; N I Walker
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.842

5.  Type I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cells.

Authors:  Ji-Eun Shin; Hyun-Jeong Kim; Ki-Rim Kim; Sun Kyoung Lee; Junhee Park; Hyungkeun Kim; Kwang-Kyun Park; Won-Yoon Chung
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-29       Impact factor: 2.629

Review 6.  The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.

Authors:  Byeong Mo Kim
Journal:  Oxid Med Cell Longev       Date:  2018-04-12       Impact factor: 6.543

Review 7.  Saponins from Chinese Medicines as Anticancer Agents.

Authors:  Xiao-Huang Xu; Ting Li; Chi Man Vivienne Fong; Xiuping Chen; Xiao-Jia Chen; Yi-Tao Wang; Ming-Qing Huang; Jin-Jian Lu
Journal:  Molecules       Date:  2016-10-05       Impact factor: 4.411

Review 8.  A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins.

Authors:  Xiaojiaoyang Li; Xiaoyu Li; Nana Huang; Runping Liu; Rong Sun
Journal:  Phytomedicine       Date:  2018-09-17       Impact factor: 5.340

9.  Investigation on ultrasound assisted extraction of saikosaponins from Radix Bupleuri.

Authors:  Shuna Zhao; Kin-Chor Kwok; Hanhua Liang
Journal:  Sep Purif Technol       Date:  2006-12-15       Impact factor: 7.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.